FTC Builds Case Against Gender-Affirming Care Providers, Raises Alarms Across Healthcare Sector

The Federal Trade Commission has assembled a team of investigators and opened probes with an apparent focus on penalizing gender-affirming medical care for minors, according to internal records and statements from agency officials. The effort, described by current and former FTC staff, signals a potential expansion of federal enforcement against healthcare providers and advocates who support transition-related treatments for young people.

Sources familiar with the matter indicate the FTC's strategy centers on consumer protection principles, examining how providers communicate about and market gender-affirming interventions for patients under 18. The agency has reportedly hired specialists with backgrounds in anti-LGBTQ+ advocacy and opened formal investigations into several clinic operators and nonprofit organizations that publicly support these treatments. Staff members working on other matters say they have observed internal pressure to prioritize cases involving gender-affirming care, with direction coming from senior leadership.

Medical providers and legal advocates warn the investigations could chill access to essential care. Professional associations including the American Academy of Pediatrics maintain that evidence-based gender-affirming treatments represent standard practice for qualifying patients. Consumer protection attorneys say the FTC's approach, if sustained, could expose practitioners to substantial liability while complicating their ability to communicate with patients and families. LGBTQ+ advocacy organizations say they have already documented a climate of fear among healthcare workers and support networks, with some clinics reporting increased difficulties maintaining malpractice coverage and referral relationships.